SG10201811454WA - Materials and methods for controlling infections - Google Patents

Materials and methods for controlling infections

Info

Publication number
SG10201811454WA
SG10201811454WA SG10201811454WA SG10201811454WA SG10201811454WA SG 10201811454W A SG10201811454W A SG 10201811454WA SG 10201811454W A SG10201811454W A SG 10201811454WA SG 10201811454W A SG10201811454W A SG 10201811454WA SG 10201811454W A SG10201811454W A SG 10201811454WA
Authority
SG
Singapore
Prior art keywords
materials
methods
infections
controlling infections
chlorhexidine
Prior art date
Application number
SG10201811454WA
Other languages
English (en)
Inventor
Carolyn Twomey
Gareth Clarke
Samuel Zaidspiner
Original Assignee
Innovation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Technologies Inc filed Critical Innovation Technologies Inc
Publication of SG10201811454WA publication Critical patent/SG10201811454WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG10201811454WA 2013-12-12 2014-12-12 Materials and methods for controlling infections SG10201811454WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361915281P 2013-12-12 2013-12-12

Publications (1)

Publication Number Publication Date
SG10201811454WA true SG10201811454WA (en) 2019-01-30

Family

ID=53367098

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201604596RA SG11201604596RA (en) 2013-12-12 2014-12-12 Materials and methods for controlling infections
SG10201811454WA SG10201811454WA (en) 2013-12-12 2014-12-12 Materials and methods for controlling infections

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201604596RA SG11201604596RA (en) 2013-12-12 2014-12-12 Materials and methods for controlling infections

Country Status (15)

Country Link
US (9) US9642820B2 (enExample)
EP (1) EP3079681B1 (enExample)
JP (2) JP2017503852A (enExample)
KR (1) KR20160096678A (enExample)
CN (1) CN105979940A (enExample)
AU (2) AU2014361828A1 (enExample)
BR (1) BR112016013199A2 (enExample)
CA (1) CA2933065C (enExample)
CL (1) CL2016001447A1 (enExample)
IL (1) IL246087A0 (enExample)
MX (1) MX388424B (enExample)
PH (1) PH12016501099A1 (enExample)
RU (1) RU2682642C1 (enExample)
SG (2) SG11201604596RA (enExample)
WO (1) WO2015089421A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
ES2940916T3 (es) 2010-12-08 2023-05-12 Convatec Technologies Inc Sistema para eliminar exudados del sitio de una herida
US10207031B2 (en) 2010-12-08 2019-02-19 Convatec Technologies Inc. Integrated system for assessing wound exudates
CN103347562B (zh) 2010-12-08 2016-08-10 康沃特克科技公司 伤口分泌液系统附件
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN105008611A (zh) 2012-12-20 2015-10-28 康沃特克科技公司 化学改性的纤维素纤维的处理
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
SG11201604596RA (en) 2013-12-12 2016-07-28 Innovation Technologies Inc Materials and methods for controlling infections
US9848604B2 (en) * 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
WO2016022441A1 (en) * 2014-08-08 2016-02-11 Innovation Technologies, Inc. Materials and methods for controlling infections with negative pressure wound therapy
GB2543544A (en) 2015-10-21 2017-04-26 Brightwake Ltd Wound dressing
EP3436820A2 (en) 2016-03-30 2019-02-06 Qualizyme Diagnostics GmbH&Co KG Detecting microbial infection in wounds
EP3936095B1 (en) 2016-03-30 2024-06-19 ConvaTec Technologies Inc. Detecting microbial infections in wounds
WO2017192944A1 (en) * 2016-05-06 2017-11-09 SaCSh Corp. Ophthalmic compositions
GB201608099D0 (en) 2016-05-09 2016-06-22 Convatec Technologies Inc Negative pressure wound dressing
BR112019000284A2 (pt) 2016-07-08 2019-04-16 Convatec Technologies Inc. aparelho de coleta de fluido
CA3030153C (en) 2016-07-08 2023-10-24 Convatec Technologies Inc. Fluid flow sensing
WO2018009880A1 (en) 2016-07-08 2018-01-11 Convatec Technologies Inc. Flexible negative pressure system
AU2017347819A1 (en) * 2016-10-26 2019-05-23 Innovation Technologies, Inc. Materials and methods for the control of biofilm
CN111093369B (zh) * 2017-08-25 2024-04-26 Az解决方案有限责任公司 用于伤口处理和冲洗的系统和方法
EP3684436B1 (en) 2017-09-22 2024-11-27 Becton, Dickinson and Company 4% trisodium citrate solution for use as a catheter lock solution
WO2019084134A1 (en) * 2017-10-24 2019-05-02 Saint Anthony Biomedical, LLC COMPOSITIONS AND METHODS FOR REDUCING INFECTION IN WOUNDS AND SURGICAL SITES
CN111836655A (zh) 2017-11-16 2020-10-27 康沃特克有限公司 流体收集设备
WO2020005785A1 (en) * 2018-06-26 2020-01-02 Innovation Technologies, Inc. Pyrogen binding composition and use of same in treatment and prevention of sepsis
JP7511585B2 (ja) 2019-06-03 2024-07-05 コンバテック リミティド 病原体を破壊して封じ込めるための方法およびデバイス
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
CN112294789B (zh) * 2020-10-15 2022-06-07 郑涛 用于防治呼吸道感染的复方制剂及其应用
JP2023550402A (ja) * 2020-11-18 2023-12-01 アンスティテュ・クリー ビグアニジンの二量体及びその治療的使用
US11722993B2 (en) * 2021-03-23 2023-08-08 Qualcomm Incorporated Techniques for configuring resources in a sidelink resource pool
US11951087B2 (en) 2021-07-27 2024-04-09 Lanny Leo Johnson Eye wash compositions and methods
WO2023052829A1 (en) * 2021-10-02 2023-04-06 Desert King Chile S.A A 3-o-monodesmosidic saponins extract, stable at physiological ph, method for preparing it from a quillaja plant extract cultured with a microbial consortium, uses and such microbial consortium

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2090354A (en) * 1936-05-14 1937-08-17 Abraham E Massman Combined medicine dropper and swab
US4299221A (en) * 1979-09-28 1981-11-10 Stryker Corporation Irrigation and suction handpiece
US4704102A (en) * 1982-09-30 1987-11-03 Geneco Inc. Method of eliminating intra abdominal infections
US5002769A (en) * 1987-03-13 1991-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for the sustained-release of chlorhexidine
IE883722L (en) * 1988-12-14 1990-06-14 Galway Dental Technology Ltd Fluid dispenser for the treatment of a dental disorder
US4925668A (en) * 1989-01-18 1990-05-15 Becton, Dickinson And Company Anti-infective and lubricious medical articles and method for their preparation
US5002528A (en) * 1989-12-15 1991-03-26 Aubrey Palestrant Percutaneous irrigation and drainage system
US5333603A (en) * 1992-02-25 1994-08-02 Daniel Schuman Endoscope with palm rest
US6558686B1 (en) * 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
JPH09301858A (ja) * 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd グルコン酸クロルヘキシジン安定化水性薬剤
US5725311A (en) 1996-07-19 1998-03-10 Sage Products, Inc. Resealable package with label peeling inhibiting means
JP3054758B2 (ja) * 1997-03-27 2000-06-19 小林製薬株式会社 外傷用組成物
US5906278A (en) 1997-10-06 1999-05-25 Sage Products, Inc. Patient bathing system
US5956794A (en) 1997-10-31 1999-09-28 Sage Products, Inc. Patient bathing system and washcloth for body cleansing
RU2166314C2 (ru) * 1999-07-06 2001-05-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
US7066932B1 (en) * 2001-05-26 2006-06-27 Map Technologies Llc Biologically enhanced irrigants
US6964653B2 (en) * 2002-02-06 2005-11-15 Felipe Negron Multi-use hygienic cleansing device
US7066916B2 (en) 2003-05-12 2006-06-27 Sage Products, Inc. Disinfectant delivery system, and method of providing alcohol-free disinfection
RU2240821C1 (ru) * 2003-06-02 2004-11-27 Научно-исследовательский институт вакцин и сывороток им. И.И.Мечникова РАМН Способ лечения урогенитальных инфекций
IL156945A0 (en) * 2003-07-15 2004-02-08 Itzhak Tavori Device and a method for orthopedic delivery of bone reconstruction medium
WO2005030297A1 (en) * 2003-09-22 2005-04-07 Innovation Technologies, Inc. Wound irrigation device and method
US20050191247A1 (en) 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
WO2007003028A1 (en) * 2005-07-01 2007-01-11 Kane Biotech Inc. Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20100087788A1 (en) * 2006-10-18 2010-04-08 Joel Rosenblatt Anti-infective alcohol catheter solution with chlorhexidine treated catheter
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
GB0716605D0 (en) 2007-08-24 2007-10-03 Univ Aston Skin antiseptics
US8696820B2 (en) * 2008-03-31 2014-04-15 Bard Access Systems, Inc. Method of removing a biofilm from a surface
EP2273989A4 (en) 2008-04-07 2013-05-01 Interface Biologics Inc POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
JP2011529898A (ja) * 2008-08-01 2011-12-15 オンディーヌ インターナショナル リミテッド Ｍｒｓａの治療用の組成物および方法
US8622996B2 (en) * 2008-10-27 2014-01-07 Pursuit Vascular, Inc. Method for applying antimicrobial to proximal end of catheter
RU2455037C2 (ru) * 2009-05-14 2012-07-10 Государственное образовательное учреждение высшего профессионального образования "Челябинская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ локальной иммунокоррекции инфекционно-воспалительных заболеваний урогенитального тракта женщин, вызванных микроорганизмами, передаваемыми половым путём
JP5639345B2 (ja) * 2009-05-27 2014-12-10 花王株式会社 バイオフィルム除去剤組成物
RU2404430C1 (ru) * 2009-07-27 2010-11-20 Ирина Дмитриевна Евтушенко Способ диагностики атрофии влагалища у женщин репродуктивного возраста в состоянии постовариоэктомии
WO2011056486A2 (en) * 2009-10-26 2011-05-12 Innovation Technologies, Inc. Devices, methods, and composition for controlling infections
US8343525B2 (en) 2009-12-22 2013-01-01 Becton, Dickinson And Company Chlorhexidine acetate antiseptic cleaning agent
DK2600869T3 (da) * 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
US8529546B2 (en) * 2010-10-21 2013-09-10 John J. Martinez Sinusal guide cannula and kit for irrigation, suction and washing
US20120150131A1 (en) * 2010-12-09 2012-06-14 Teleflex Medical Incorporated Polymer for Controlling Delivery of Bioactive Agents and Method of Use
EP2750625A4 (en) * 2011-08-31 2015-08-19 Univ Columbia REDUCTION OF BIOFILMS ON MEDICAL DEVICES
US9327095B2 (en) * 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
CN103211805A (zh) * 2013-04-18 2013-07-24 江苏健裕健康医疗器械有限公司 洗必泰葡萄糖酸盐复合消毒液
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
SG11201604596RA (en) * 2013-12-12 2016-07-28 Innovation Technologies Inc Materials and methods for controlling infections

Also Published As

Publication number Publication date
IL246087A0 (en) 2016-07-31
US10682318B2 (en) 2020-06-16
WO2015089421A1 (en) 2015-06-18
US11033517B2 (en) 2021-06-15
US20210259996A1 (en) 2021-08-26
US9931310B2 (en) 2018-04-03
US20160279080A1 (en) 2016-09-29
US20150164829A1 (en) 2015-06-18
KR20160096678A (ko) 2016-08-16
US9668989B2 (en) 2017-06-06
AU2014361828A1 (en) 2016-06-30
MX388424B (es) 2025-03-19
CA2933065A1 (en) 2015-06-18
AU2018271354A1 (en) 2019-01-17
JP2019189613A (ja) 2019-10-31
US20180055793A1 (en) 2018-03-01
US10226437B2 (en) 2019-03-12
US9642820B2 (en) 2017-05-09
JP2017503852A (ja) 2017-02-02
US20200289435A1 (en) 2020-09-17
RU2682642C1 (ru) 2019-03-20
AU2018271354B2 (en) 2020-05-21
CA2933065C (en) 2021-08-24
MX2016007679A (es) 2017-02-28
US20190307709A1 (en) 2019-10-10
BR112016013199A2 (pt) 2020-06-30
EP3079681A4 (en) 2017-11-22
US10172813B2 (en) 2019-01-08
CL2016001447A1 (es) 2017-04-07
US10507191B2 (en) 2019-12-17
PH12016501099A1 (en) 2016-07-11
US20180221311A1 (en) 2018-08-09
CN105979940A (zh) 2016-09-28
EP3079681A1 (en) 2016-10-19
SG11201604596RA (en) 2016-07-28
US20180055794A1 (en) 2018-03-01
US20160271079A1 (en) 2016-09-22
US11559503B2 (en) 2023-01-24
EP3079681B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
SG10201811454WA (en) Materials and methods for controlling infections
ZA201708692B (en) Antibacterial compounds
MX2015010125A (es) Derivados de piridazinona-amidas.
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12015502788A1 (en) Antibody formulations and methods
PH12016500207A1 (en) Anti-infective compounds
WO2015003816A3 (en) Cystobactamides
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
CL2015002897A1 (es) Inhibidores de bace1
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2015009818A (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple.
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
SMT201900692T1 (it) Composizione per l&#39;uso del trattamento delle infezioni batteriche
IN2013MU03216A (enExample)
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
MX2015008947A (es) Nuevas composiciones antifungicas.
UA93017U (uk) Препарат &#34;нановулін-врх&#34;
IN2013MU01983A (enExample)
TH148347B (th) &#34;ส่วนประกอบสารต้านอนุมูลอิสระที่มีปริมาณแคลอรีต่ำ, กระบวนการได้สิ่งดังกล่าวมา และการใช้สิ่งดังกล่าว&#34;